Characteristics of prognosis and response to an imidazole carboxamide in malignant melanoma.
D000328:Adult; D000577:Amides / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014226:Triazenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D014226:Triazenes